EastGate Biotech (OTC: PINK: ETBI) Announces Positive Phase II Clinical Results of its Innovative Liquid Insulin Mouth Rinse Solution for Type 2 Diabetes

Following a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a day […]